Nancy J. Hutson - Aug 18, 2021 Form 4/A - Amendment Insider Report for PhaseBio Pharmaceuticals Inc (PHASQ)

Role
Director
Signature
/s/ John P. Sharp, Attorney-in-fact
Stock symbol
PHASQ
Transactions as of
Aug 18, 2021
Transactions value $
$9,240
Form type
4/A - Amendment
Date filed
5/20/2022, 04:47 PM
Date Of Original Report
Aug 19, 2021
Previous filing
Aug 17, 2021
Next filing
Oct 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Purchase $9.24K +3K +300% $3.08* 4K Aug 18, 2021 Held in an individual retirement account for the benefit of the Reporting Person F1
holding PHASQ Common Stock 33.8K Aug 18, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.07 to $3.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
F2 Amended to report direct share ownership.